SEC Form 4 · accession 0001467373-15-000043
Accenture plc · ACN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Sell
Officer — Grp Chief Exec-Com, Med & Tech
Period of report
Jan 5, 2015
Accepted (ET)
Jan 7, 2015 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467373
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary sharesF1 | Jan 5, 2015 | A | 1,567 | $87.75 | A | 31,501 | D | |
| Class A ordinary sharesF2 | Jan 5, 2015 | A | 2,006 | $0.00 | A | 33,507 | D | |
| Class A ordinary sharesF4 | Jan 5, 2015 | S | 595 | $87.5199 | D | 32,912 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.
- F2Grant made pursuant to the Accenture Voluntary Equity Investment Program.
- F3Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan.
- F4The transaction was executed in multiple trades at prices ranging from $87.33 to $88.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.